ABSTRACT Artificial Intelligence is rapidly transforming allergology by enhancing diagnosis, risk prediction, automation, patient communication, education, and therapy development. Machine learning approaches, including convolutional neural networks, recurrent architectures, and transformer‐based models, enable analysis of complex datasets from ...
Sebastian Seurig +2 more
wiley +1 more source
Enhancing Drug Hypersensitivity Reaction Documentation Through a Clinical Surveillance Tool. [PDF]
Reid JM +5 more
europepmc +1 more source
Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres +4 more
wiley +1 more source
Drug hypersensitivity to vancomycin confirmed by basophil activation test: case report. [PDF]
Zidane Z +9 more
europepmc +1 more source
Correction to "Methotrexate-Induced Drug Hypersensitivity Syndrome Presenting With Acute Cerebral Infarction in End-Stage Renal Disease: A Case Report". [PDF]
europepmc +1 more source
The impact of repeated drug desensitisation on quality of life in drug hypersensitivity. [PDF]
Gorgulu Akin B +9 more
europepmc +1 more source
Fixed Solar Eruption: A Case Report
ABSTRACT Fixed eruption is characterized by recurrent lesions at identical anatomical sites after exposure to a trigger. Although most cases are drug‐induced, ultraviolet (UV) radiation has also been reported as a causative factor. We report a case of fixed solar eruption diagnosed by histopathology and 308 nm excimer light phototesting.
Yukiko Tateno +3 more
wiley +1 more source
Prevalence and management of immediate drug hypersensitivity observed during antineoplastic drug therapy. [PDF]
Rasmussen TH +4 more
europepmc +1 more source
Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense +4 more
wiley +1 more source
Blended reactions and angioedema are common in patients with cross-reactive nonsteroidal anti-inflammatory drug hypersensitivity. [PDF]
Pham DL +11 more
europepmc +1 more source

